In Vitro and in Vivo Efficacy of the Triazole TAK-187 Against Cryptococcus Neoformans

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.42.10.2630

Full Text

Abstract

Available in

Categories

Infectious Diseases

Date

October 1, 1998

Authors

Wiley A. Schell

Gisele Madeira Duboc De Almeida

Richard K. Dodge

John R. Perfect

Publisher

American Society for Microbiology

Related search

In Vitro and in Vivo Activity of 2,4-Diamino-6-[2-(3,4-Dichlorophenyl)acetamido] Quinazoline Against Cryptococcus Neoformans

Experimental Biology and Medicine

Molecular Biology

English

Fungicidal Properties of Defensin NP-1 and Activity Against Cryptococcus Neoformans in Vitro.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Isotype Switching Increases Efficacy of Antibody Protection Against Cryptococcus Neoformans Infection in Mice

Infection and Immunity

Infectious Diseases

English

In Vitro Interaction of Flucytosine With Conventional and New Antifungals Against Cryptococcus Neoformans Clinical Isolates

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Receptor-Mediated Clearance of Cryptococcus Neoformans Capsular Polysaccharide in Vivo

Infection and Immunity

Infectious Diseases

English

In Vitro Susceptibility of the Opportunistic Fungus Cryptococcus Neoformans to Anthelmintic Benzimidazoles.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Biochemical Comparison of the Cu,Zn Superoxide Dismutases of Cryptococcus Neoformans Var. Neoformans and Cryptococcus Neoformans Var. Gattii.

Infection and Immunity

Infectious Diseases

English

Phenotypic Switching of Cryptococcus Neoformans and Cryptococcus Gattii

Applied Microbiology

English

Human Neutrophil-Mediated Nonoxidative Antifungal Activity Against Cryptococcus Neoformans

Infection and Immunity

Infectious Diseases

English